PRF Technologies PRFX
NASDAQ PRFX
$0.74 +0.02 (+3.37%)
As of: Oct 20, 2026 · 3:58 PM EDT

PRF Technologies (PRFX) Convertible Debt (2019)

Updated

PRF Technologies (PRFX) reported Convertible Debt of $4.42 million for the quarter ended Dec 31, 2019.

Analysis

PRF Technologies (PRFX) Convertible Debt (2019) Analysis & Trends

  • By year, Convertible Debt came in at $3.69 million in the year ended Dec 31, 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 PRF Technologies 492,329.90 -22.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 4.42 Mn
API Access

PRF Technologies Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=PRFX&period=max&api_key=YOUR_API_KEY